Tag: GlobeNewswire

LAS VEGAS, Oct. 08, 2026 (GLOBE NEWSWIRE) — Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) announced today a significant restructuring of its executive leadership and investor relations functions in order to prepare the Company for its next phase of corporate and operational growth.

Effective October 2, 2026, Timothy Gomez is appointed as Chief Executive Officer of Asia Broadband replacing Cris Torres, while Fernando Ramirez is named the Chief Financial Officer, replacing Bernard Velez.

The executive leadership transition is seen as an important milestone for the corporate growth of Asia Broadband Inc. as the Company expands the scope and complexity of its precious metals operations, mining assets, exploration projects, technology innovations and its digital asset business.

Strengthening the Leadership of Asia Broadband

In recent years, the Company has undergone a number of significant changes in terms of its operations, business and assets. Over this period, AABB has considerably expanded the scope of its precious metals production and mining operations in Mexico, advanced the asset base and further developed its exploration activities, invested in its proprietary and licensed mining technologies and worked on building its precious metals backed digital assets ecosystem.

Taking into account the growing scope of its operations, AABB has decided to reorganize the management functions and strengthen the leadership of the Company.

Appointing New CEO and CFO

Appointing Timothy Gomez as Chief Executive Officer adds a greater depth of management experience and strategic focus to the operations of the Company. As the new CEO of Asia Broadband Inc., Mr. Gomez will be responsible for directing the overall strategy of the Company, coordinating all principal operating divisions and implementing the Company’s corporate strategy.

Fernando Ramirez is appointed as the Chief Financial Officer of the Company and will be in charge of financial management, as well as all other related financial functions. The new executive team will work together with the current personnel of the Company in order to maintain continuity and consistency of all the existing initiatives while identifying ways to increase efficiency and optimize the financial management and processes of the Company.

The Company wishes to extend its sincere gratitude to former CEO Cris Torres and former CFO Bernard Velez for their invaluable efforts, leadership and commitment to helping the Asia Broadband reach its current state. Under their tenure, the Company successfully progressed in the development of the operations, mining asset base and achieved the strategic vision which has been guiding the development of the Company.

Maintaining the Corporate Vision and Goals Set by the Previous Management

The new management team of the Company is committed to maintaining the strategic vision and goals set by the previous management of Asia Broadband.

“Our objective is to build upon the foundation and the goals set by Cris,” said Timothy Gomez, the newly appointed CEO of Asia Broadband Inc. “We aim to take the base which was built up during his tenure and add the required managerial expertise, structure and execution capability to bring the Company to the next level.”

New Investor Relations Function

The appointment of the new management functions of the Company follows an important organizational change implemented earlier this year.

Effective August 1, 2026, the Company has engaged a new Investor Relations team. This is an important step to provide investors with the corporate communication and to streamline the flow of information between the Company and its stakeholders.

Expanding Operating Platform

The management transition of the Company comes at an important time in the development of Asia Broadband Inc.

During the current year, the Company has successfully continued its expansion of precious metals production and mining operations in Mexico as well as has pursued several strategically important initiatives of the Company.

During the year 2026, AABB has reported significant growth of revenues from increased gold and silver production in its Etzatlán processing operations, exploration and drilling operations at Picachos IV, development and commercialization initiatives concerning the mining technologies and expansion of its mining asset portfolio in the Etzatlán region.

The Company has also advanced its work with its precious metals backed digital asset ecosystem and corresponding technology infrastructure. Considering the growing diversification of its operations, management believes that the new operations structure of the Company will enhance the expansion of all these initiatives.

Appointment of the new CEO and CFO, as well as the restructuring of the Investor Relations function, are aimed at creating the optimal management structure to further elevate the Company going forward.

Focus on Efficiency and Long-Term Shareholder Value Creation

Under the leadership of the new executive team, the priorities of the Company will remain the same – expansion of precious metals production, development and expansion of mining assets, strategic growth and long-term creation of the value for the shareholders of the Company.

Also, the new management will regularly and strategically analyze the operations, corporate structure and key initiatives of the Company to identify and implement changes to increase the efficiency, enhance financial controls and prioritize efforts for the long-term development of the Company.

Timothy Gomez, Chief Executive Officer of Asia Broadband Inc., stated: “Asia Broadband Inc. is going through an important milestone in its evolution. The Company has built a diversified portfolio of the mining, production, technology and digital asset initiatives and our objective is to build the management structure which would allow us to take full advantage of them.”

“Our priorities will include management efficiency and a focus on the core operations and initiatives to advance the projects rapidly that will bring significant long-term value to the Company and its shareholders.”

“I am eagerly looking forward to working with my new colleague Fernando, the Company’s operations team and our newly fortified Investor Relations department, while moving Asia Broadband into the next phase of its development.”

The Company will announce additional information regarding the new executive leadership, its strategic priorities and initiatives as the material developments occur.

About Asia Broadband

Asia Broadband Inc. (OTC: AABB) is a resource company focused on the production of precious metals and the accumulation of physical gold and silver holdings. The Company utilizes its specific geographic expertise, experience and extensive industry contacts to facilitate the expansion of precious metals property holdings and production in Mexico. The Company’s industry and business integration in Mexico and its asset diversification are unique strengths of AABB that differentiate it from other companies and creates distinctive value for shareholders. Additionally, the Company has a digital assets business segment with its AABBG and AABBS mine-to-token gold and silver-backed cryptocurrencies within its own proprietary GoldAxis Wallet and the unique Golden Baboons Mining Club and Shorts Rascal Club Non-Fungible Token (NFT) collections. AABB expects its token to become a world-wide standard of exchange that is stable, secured and trusted with gold backing, while having the added benefit of demand based price appreciation. These are unique and outstanding qualities relative to other cryptocurrencies and digital asset developers.

Contact the Company at:

General Email:	ir@asiabroadbandinc.com
Token Support:	support@aabbgmine2token.com
Company Websites:	www.asiabroadbandinc.com
	www.aabbgmine2token.com
	www.goldenbaboons.com
Phone:	702-744-4785

Forward-Looking Statements are contained in this press release within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on the Asia Broadband Inc.’s (the “Company”) expected current beliefs about the Company’s business, which are subject to uncertainty and change. The operations and results of the Company could materially differ from what is expressed or implied by the statements made above when industry, regulatory, market and competitive circumstances change. Further information about these risks can be found in the annual and quarterly disclosures the Company has published on the OTC Markets website. The Company is under no obligation to update or alter its forward-looking statements as future circumstances, events and information may change.

Source: Asia Broadband Inc.

HOUSTON, Oct. 08, 2026 (GLOBE NEWSWIRE) — HyOrc Corporation (OTCQB: HYOR) today reported strong industry engagement following the Company’s presentation at the Dow Jones: OPIS World Methanol Conference in Rotterdam, where CEO Reginald Fubara presented HyOrc’s waste-to-methanol technology and commercial deployment strategy.

The presentation focused on HyOrc’s proprietary refuse-derived fuel (RDF)-to-methanol platform and the Company’s target of producing low-carbon methanol at a levelized cost of approximately €350 per tonne.

HyOrc’s targeted economics are driven in part by its differentiated feedstock model. Rather than purchasing conventional feedstock, the Company’s platform is designed to utilize prepared RDF derived from non-recyclable waste streams that can attract gate fees. HyOrc also integrates process heat recovery and internal power generation to reduce external energy requirements associated with methanol production.

“A recurring issue throughout the conference was the economics of producing low-carbon methanol at scale,” said Reginald Fubara, CEO of HyOrc. “Our approach starts from a fundamentally different position: using waste as the carbon resource and designing the process around competitive underlying economics. The level of interest following our presentation showed us that this approach resonated strongly with the industry.”

Following the presentation, representatives of major international energy companies and other industry participants approached HyOrc to discuss the Company’s technology, commercial economics and potential areas of cooperation.

The discussions are preliminary, and no agreements or commercial arrangements have been entered into as a result of the conference. However, management believes the level and quality of inbound interest provides encouraging evidence of market interest as HyOrc advances its first Porto commercial waste-to-methanol deployment.

Fubara added. “We are now following up on those discussions and evaluating where there may be genuine opportunities to work together as we move into commercial deployment.”

The Dow Jones World Methanol Conference brings together methanol producers, energy companies, traders, technology providers and other industry participants from across the global methanol value chain.

About HyOrc Corporation
HyOrc Corporation (OTCQB: HYOR) develops and commercializes patented hydrogen-capable combustion and waste-to-fuel systems for the shipping, rail, and off-grid power sectors.

Website: www.hyorc.com Press Contact: comms@hyorc.com

Forward-Looking Statements
This release contains forward-looking statements under Sections 27A and 21E of the Securities Acts of 1933 and 1934. These statements involve risks and uncertainties that may cause actual results to differ materially. Factors are described in Company filings with the SEC. The Company undertakes no obligation to update such statements.

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/331701d1-538d-4116-bd4f-4115ea6d7eb4

https://www.globenewswire.com/NewsRoom/AttachmentNg/0614c786-b5ab-4bd4-b3bb-48ad9bfb9ad6

PITTSBURGH, Oct. 08, 2026 (GLOBE NEWSWIRE) — Duolingo, Inc. (Nasdaq: DUOL), the world’s leading mobile learning platform, will announce its results for the third quarter ending September 30, 2026, following the close of the U.S. market on Tuesday, November 3, 2026. The Company will host a video webcast at 5:00 p.m. ET on that day.

The live video webcast will be accessible to the public through Duolingo’s Investor Relations website at https://investors.duolingo.com. A replay of the event will be available two hours after the live event and archived on our Investor Relations website.

About Duolingo
Duolingo is the leading mobile learning platform globally. Its flagship app has organically become the world’s most popular way to learn languages and the top-grossing app in the Education category on both Google Play and the Apple App Store. With technology at the core of everything it does, Duolingo has consistently invested to provide learners a fun, engaging, and effective learning experience while remaining committed to its mission to develop the best education in the world and make it universally available.

Contact Information

Investors:
Deborah Belevan, IRC, CPA
ir@duolingo.com

Media:
Michelle Scully
press@duolingo.com

Preliminary revenue of $2.3 million represents the highest quarterly revenue reported, and approximately 30% sequential quarterly growth and 27% growth over the same period last year

Performance reflects continued adoption for first-generation LungFit PH; second-generation system remains under FDA review

Reaffirms revenue guidance of $8 million for CY2026 and $16-$18 million for CY2027

GARDEN CITY, N.Y., Oct. 08, 2026 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patients’ lives, today announced preliminary, unaudited revenue of approximately $2.3 million for the quarter ended September 30, 2026. The preliminary revenue represents an increase of approximately 30% compared with the quarter ended June 30, 2026 and 27% compared with the same quarter last year, and reflects the successful rollout of the Company’s enhanced commercial execution strategy for LungFit PH.

“Our strong revenue growth in the quarter ended September 30, 2026 reflects continued adoption of LungFit PH and the value hospitals see in our cylinder-free nitric oxide technology,” said Robert Goodman, Chief Executive Officer of Beyond Air. “Over the years, we have refined our first-generation system through a series of enhancements and improvements for ease of use. The first-generation LungFit PH has established a strong track record of reliable nitric oxide delivery and has become a trusted system among our hospital customers. Our second-generation system remains under review by the FDA, and we expect demand for the LungFit PH platform to increase significantly following FDA approval. We continue to be pleased with the progress we are seeing with the ongoing PMA supplement process. Adding transport capability will qualify Beyond Air as a single source nitric oxide provider, which is the current standard across most U.S. hospital systems.”

Revenue Guidance for CY2026 and CY2027

The Company reaffirms its previously issued revenue guidance of $8 million for calendar year 2026, which excludes revenue from the second-generation LungFit PH system. The Company also reaffirms its revenue guidance of $16 million to $18 million for calendar year 2027, which includes anticipated revenue from the second-generation system, pending FDA approval.

The preliminary revenue figure set forth above is unaudited, is based on management’s preliminary estimates and information available to the Company as of the date of this press release, and remains subject to the completion of the Company’s financial closing procedures and the review of its interim financial statements by its independent registered public accounting firm, which has not audited, reviewed or performed any procedures with respect to the preliminary figure. Actual results may differ materially from the preliminary figure.

The Company will report its complete financial results for the quarter ended September 30, 2026 in November 2026.

About Beyond Air^®, Inc.

Beyond Air is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. The Company has received FDA approval and CE Mark for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. For more information, visit www.beyondair.net.

About LungFit^®

Beyond Air’s LungFit is a cylinder-free, phasic flow generator and delivery system designated as a medical device by the U.S. Food and Drug Administration (FDA). The ventilator-compatible version of the device can generate NO from ambient air on demand for delivery to the lungs at concentrations ranging from 1 ppm to 80 ppm. The LungFit system could potentially replace large, high-pressure NO cylinders, providing significant advantages in the hospital setting, including greatly reducing inventory and storage requirements, improving overall safety by eliminating NO2 purging steps, and offering other operational benefits.

LungFit can also deliver NO at concentrations at or above 80 ppm for potentially treating severe acute lung infections in the hospital setting (e.g., COVID-19, bronchiolitis) and chronic, refractory lung infections in the home setting (e.g., NTM). With the elimination of cylinders, Beyond Air intends to offer NO treatment in the home setting.

About Nitric Oxide

Nitric Oxide (NO) is a potent molecule, naturally synthesized in the human body, proven to play a critical role in a broad array of biological functions. In the airways, NO targets the vascular smooth muscle cells that surround the small resistance arteries in the lungs. Currently, exogenous inhaled NO is used in adult respiratory distress syndrome, post certain cardiac surgeries and persistent pulmonary hypertension of the newborn to treat hypoxemia. Additionally, NO is believed to play a key role in the innate immune system and in vitro studies suggest that NO possesses anti-microbial activity not only against common bacteria, including both gram-positive and gram-negative, but also against other diverse pathogens.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements regarding the Company’s preliminary, unaudited revenue for the quarter ended September 30, 2026; the Company’s revenue guidance for calendar year 2026 and 2027; demand for, and hospital adoption of, the Company’s LungFit PH systems; the FDA’s review of the Company’s PMA supplement for the second-generation LungFit PH system and the potential approval, intended use and commercial benefits of that system; and the Company’s ability to scale its infrastructure. Forward-looking statements may be identified by words such as “anticipate,” “believe,” “expect,” “intend,” “plan,” “potential,” “will,” “would,” “could,” “may,” and similar expressions, or by the use of future tense.

Because forward-looking statements relate to future events, they are subject to inherent risks and uncertainties, many of which are beyond the Company’s control, that could cause actual results to differ materially from those expressed or implied in such statements. These risks and uncertainties include, but are not limited to, the possibility that the Company’s final revenue for the quarter ended September 30, 2026 differs from the preliminary figure as a result of the completion of its financial closing procedures, final adjustments or other developments; the Company’s ability to achieve its revenue guidance, which is based on assumptions regarding demand, hospital adoption, pricing and other factors that may not be realized; whether the FDA approves the Company’s PMA supplement for the second-generation LungFit PH system, which may not occur in a timely manner or at all; market acceptance of the Company’s products and competition in the nitric oxide market; the Company’s ability to obtain the financing necessary to fund its operations and to satisfy its debt obligations as they come due; the Company’s ability to maintain the listing of its common stock on The Nasdaq Stock Market; and other risks described in the “Risk Factors” section of Beyond Air, Inc.’s most recent Annual Report on Form 10-K and subsequent filings with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made and, except as required by law, the Company undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

CONTACTS:

Investor Relations contact
Corey Davis, Ph.D.
LifeSci Advisors, LLC
cdavis@lifesciadvisors.com
(212) 915-2577

Unprecedented collaboration merges a massive digital publishing network with Cesar Millan’s global authority, powered by advanced AI content technology.

NEW YORK, Oct. 08, 2026 (GLOBE NEWSWIRE) — Xcel Brands, Inc. (NASDAQ: XELB) and Paradium.AI, Inc. (NYSE American: PAAI), owner of iconic media brands including Parade, Men’s Journal, and more, today announced a transformative agreement to launch PetHelpful x Trust·Respect·Love by Cesar Millan. Targeted for a third-quarter 2027 retail launch, the co-brand represents a major evolution in the consumer lifestyle space, uniting a premier celebrity expert with a massive, always-on digital publishing engine.

The collaboration bridges a critical gap in modern retail. While traditional publishing brands offer massive reach but lack a definitive, trusted “face,” and celebrity category experts possess deep authority but lack an always-on promotional and educational commerce engine, this partnership delivers both.

The comprehensive co-brand will span multiple pet categories. Xcel Brands will leverage its proven expertise in orchestrating strategic retail partnerships by collaborating with a network of premier, licensed operating partners to develop and manufacture the line. Trust·Respect·Love by Cesar Millan brings Cesar’s decades of work with dogs and their owners into premium products built on his core principles, utilizing the cleanest, safest, and best materials available worldwide.

“Trust, respect, and love are the foundation of every relationship between a person and their dog. I’ve spent more than twenty five years helping families build that foundation, and the way they care for their dogs every day is part of it,” said Cesar Millan. “With PetHelpful, owners get my guidance and products made to the same standard, in the same place.”

“Pet owners go to PetHelpful when they’re looking for answers. Cesar has spent his career giving them those answers,” said Robert D’Loren, Chairman and CEO of Xcel Brands.

To fuel this commerce machine, Paradium will deploy its proprietary Cutter Studios technology, an advanced AI platform that ingests long-form video content and seamlessly adapt it into dozens of highly engaging, bite-sized shoppable videos and written articles. This ensures a steady, targeted stream of educational and promotional content across Parade, PetHelpful, and Cesar Millan’s own platforms, which together boast a combined reach of over 21 million social media followers and 31 million monthly readers.

“By combining Cesar’s unparalleled expertise with our Cutter Studios AI technology, we are transforming passive readership into active, educated commerce,” said Lisa Delaney, GM & Chief Content Officer of Paradium.AI Lifestyle. “We are effectively building an always-on educational platform where pet owners can consume bite-sized, trusted advice, and then purchase the premium products necessary to act on it.”

About Xcel Brands, Inc.
Xcel Brands, Inc. (NASDAQ: XELB) is a media and consumer products company engaged in the design, licensing, marketing, live streaming, and social commerce sales of branded apparel, footwear, accessories, fine jewelry, home goods, pet products and other consumer products, and the acquisition of dynamic consumer lifestyle brands. Xcel was founded in 2011 with a vision to reimagine shopping, entertainment, and social media as social commerce. Xcel is an industry leader in developing influencer led brands and owns the Halston and C. Wonder brands, as well as the co-branded influencer led brands Tower Hill by Christie Brinkley, Trust. Respect. Love by Cesar Millan, GemmaMade by Gemma Stafford and OFF/DUTY by Coco Rocha brand and holds a long-term license agreement in Mesa Mia by Jenny Martinez. Xcel also owns and manages the Longaberger by Shannon Doherty brand through its controlling interest in Longaberger Licensing, LLC. Xcel is pioneering a modern consumer products sales strategy which includes the promotion and sale of products under its brands through interactive television, digital live-stream shopping, social commerce, brick-and-mortar retailers, and e-commerce channels to be everywhere its customers’ shop. The company’s previously owned and current brands have generated more than $5 billion in retail sales via livestreaming in interactive television and digital channels alone and has over 20,000 hours of content production time in live-stream and social commerce. The brand portfolio reaches more than 46 million social media followers with broadcast reaching 200 million households. Headquartered in New York City, Xcel Brands is led by an executive team with significant live streaming, production, merchandising, design, marketing, retailing, and licensing experience, and a proven track record of success in elevating branded consumer products companies. For more information, visit www.xcelbrands.com.

For further information please contact:
Xcel Brands
media@xcelbrands.com

About Paradium.AI, Inc.
Paradium.AI, Inc. (NYSE American: PAAI) is a technology leader in IP, data and commerce that builds and operates a unified, AI-powered ecosystem designed to empower creators, media entrepreneurs, publishers and brands to perform at the speed and scale of AI. Through our core technology platforms Encore, InfoSentience and Cutter Studios, we provide the tools, data and reach that enable businesses to serve and grow audiences and optimize for revenue success. Visit us at Paradium.AI to learn more.

Forward-Looking Statements
This press release contains forward-looking statements, including statements about the planned launch, product categories, timing, and marketing support for the PetHelpful x Trust·Respect·Love by Cesar Millan co-brand. These statements are subject to risks and uncertainties, including the execution of definitive agreements, securing retail distribution, and product development timelines. Actual results may differ materially.

MIAMI, Oct. 08, 2026 (GLOBE NEWSWIRE) — UMeWorld Inc. (OTCQB: UMEW) (“UMeWorld” or the “Company”) today announced that its common stock has been approved for trading on the OTCQB Venture Market, effective October 8, 2026. The Company also announced that it has entered into an engagement agreement with ARC Group Securities, LLC (“ARC”) to support a proposed uplisting to the Nasdaq Capital Market and an associated capital raising initiative.

The Company’s common stock will continue to trade under the symbol “UMEW.”

The OTCQB upgrade marks a milestone in UMeWorld’s capital markets strategy as the Company pursues a national securities exchange listing. The engagement of ARC establishes an investment banking relationship to support the proposed uplisting process. UMeWorld is preparing the corporate, financial and registration materials required for the process, with the objective of broadening investor participation and strengthening access to capital.

“Moving to OTCQB and engaging ARC mark important milestones in UMeWorld’s capital markets strategy,” said Michael Lee, Chief Executive Officer of UMeWorld. “Our objective is to broaden investor participation and strengthen access to capital. We are now focused on preparing the financial, corporate and registration materials needed to pursue a Nasdaq Capital Market listing.”

The proposed Nasdaq uplisting and any associated financing remain subject to applicable listing requirements, regulatory review, definitive transaction documentation and market conditions. The ARC engagement does not constitute a completed financing or approval for listing on Nasdaq. There can be no assurance that either transaction will be completed.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction.

About UMeWorld Inc.

UMeWorld Inc. (OTCQB: UMEW) is an industrial biotechnology and renewable fuels developer focused on sustainable aviation fuel (“SAF”). The Company is advancing a proposed SAF biorefinery targeting initial SAF production of approximately 200,000 metric tonnes per year and has announced an investment in single-cell oil (“SCO”) technology to support the commercialization of microbial oil as a potential future SAF feedstock.

Forward-Looking Statements

This press release contains forward-looking statements concerning a proposed Nasdaq uplisting, capital raising, investor participation, the proposed SAF biorefinery and microbial oil commercialization. These statements reflect current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially, including the Company’s ability to satisfy Nasdaq’s initial listing requirements, financing availability, regulatory review, market conditions, engineering and site selection, project costs, feedstock availability, technology scale-up and qualification, and execution of definitive agreements. The Company undertakes no obligation to update these statements except as required by applicable law.

Media & Investor Contact:
UMeWorld Inc.
Investor Relations
Email: investors@umeworld.com
Website: www.umeworld.com

Board seat at Europe’s chemical recycling industry association comes as EU regulatory framework for circular plastics takes shape and Aduro advances its FOAK Plant at Chemelot, the Netherlands

LONDON, Ontario, Oct. 08, 2026 (GLOBE NEWSWIRE) — Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (TSX: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21^st century, today announced that Eric Appelman, Chief Revenue Officer, has been elected as a Board Member of Chemical Recycling Europe (“CRE”) for the 2026–2028 mandate. The election took place during the CRE General Assembly on September 29, 2026, in Brussels, ahead of the CRE Annual Conference, “Getting Ready for 2030 Targets: Powering Circular Plastics Made in Europe,” where Appelman presented Aduro’s Hydrochemolytic™ Technology (“HCT”) and the Company’s scale-up pathway for the chemical recycling of polyolefins.

CRE is the European trade association representing companies active in chemical recycling technologies and engages with policymakers, industry participants and other stakeholders to support the development of circular plastics markets. Its Board is elected for two-year mandates, bringing together representatives with experience across technology development, project deployment and market development. For the coming period, CRE leadership has identified priorities that include policy frameworks that enable continued investment, stronger demand and offtake for circular materials, implementation of recycled-content and mass-balance provisions, and greater cooperation across the plastics value chain. CRE has also placed increased emphasis on translating European policy objectives into practical conditions that support market growth and future industrial development.

Appelman brings 35 years of experience in the international chemical industry across technical, commercial, innovation and strategic roles. He began his career at Unilever, later served as Technical Director for Marine and Protective Coatings at Sigma Coatings, Europe’s second-largest paint company at that time, and as Executive Vice President at Perstorp, a Swedish chemical multinational, with responsibilities spanning innovation, market development and corporate strategy. Before joining Aduro, Appelman spent six years at Brightlands Chemelot Campus, including as Executive VP of Business Development Chief Technology Officer and Marketing & Sales Director. During his tenure, he helped attract approximately 60 innovative companies and startups to the campus and was involved in the Cracker of the Future initiative, which brought together major chemical companies to explore the electrification of steam cracking. Combined with his knowledge of European regulatory frameworks and the Chemelot ecosystem, where Aduro is developing its FOAK Plant, this background provides a relevant perspective for the work of CRE.

CRE’s work comes as the European regulatory framework for circular plastics continues to evolve. The Packaging and Packaging Waste Regulation (“PPWR”) establishes minimum recycled-content requirements across several categories of plastic packaging and requires further rules governing the calculation and verification of recycled content. Separately, EU rules adopted in 2026 for recycled-content calculation in single-use plastic beverage bottles recognize chemical recycling and establish mass-balance accounting where eligible recycled material cannot be physically traced through shared production systems. These developments form part of the broader market and regulatory environment on which CRE is focused.

Aduro continues to advance multiple workstreams supporting the commercialization of HCT in Europe. Operating campaigns at the NGP Pilot Plant are generating technical and product data to support scale-up, while engineering, permitting, site integration and project-development activities continue for the planned 10,000 metric-tonne-per-year FOAK Plant at Chemelot Industrial Park in the Netherlands. In parallel, the Company is progressing feedstock development, customer engagement, downstream product qualification and commercial activities intended to support future deployment. Through his role on the CRE Board, Appelman will contribute to the association’s work to advance policy, regulatory and market frameworks that support investment in chemical recycling and strengthen its role in Europe’s circular plastics economy.

“Europe is entering an important phase for chemical recycling as circularity objectives translate into market demand, investment decisions and industrial projects,” said Eric Appelman, Chief Revenue Officer at Aduro. “CRE brings together companies and perspectives around the practical steps needed to support that progress. I look forward to contributing my experience from across the chemical sector, together with what we are learning through the scale-up work underway at Aduro, while working with fellow Board members and CRE members to support the continued development of chemical recycling in Europe.”

“Eric brings deep experience across technology development, market strategy and the European chemical industry, and we believe that experience will be valuable to CRE and its members,” said Ofer Vicus, Chief Executive Officer of Aduro. “Aduro is at an important stage in its own scale-up, and our team is intensely focused on the work ahead. At the same time, we believe it is important to contribute experience to the broader industry. We are pleased to support Eric in taking on this additional responsibility and contributing to CRE’s work as chemical recycling continues to develop in Europe.”

Aduro joined Chemical Recycling Europe in March 2026, expanding the Company’s participation in European industry initiatives related to chemical recycling. The 2026–2028 CRE Board is led by Valentijn de Neve of BlueAlp as President, Daniel Odenthal of ARCUS Greencycling as Vice-President and Dimitri Daniels of Helix Projects as Treasurer, with Carlos Monreal of Plastic Energy and Eric Appelman of Aduro serving as Board Members. Aduro congratulates the other members elected to the Board and looks forward to their collective contribution to the continued development of chemical recycling in Europe.

About Aduro Clean Technologies

Aduro Clean Technologies is a developer of patented water-based technologies to chemically recycle waste plastics; convert heavy crude and bitumen into lighter, more valuable oil; and transform renewable oils into higher-value fuels or renewable chemicals. The Company’s Hydrochemolytic™ technology relies on water as a critical agent in a chemistry platform that operates at relatively low temperatures and cost, a game-changing approach that converts low-value feedstocks into resources for the 21st century.

For further information, please contact:

Abe Dyck, Head of Corporate Development / Investor Relations
ir@adurocleantech.com
+1 226 784 8889

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable Canadian securities laws and “forward-looking statements” within the meaning of applicable U.S. securities laws, including the U.S. Private Securities Litigation Reform Act of 1995.

Forward-looking information in this news release includes, but is not limited to, statements regarding Eric Appelman’s expected participation in the activities of the Chemical Recycling Europe Board; Aduro’s continued engagement with European industry participants and stakeholders; the continued advancement of Hydrochemolytic™ Technology from pilot operations toward industrial deployment; the use of NGP Pilot Plant operating data to inform the Company’s FOAK Program at Chemelot; the planned development and advancement of the Company’s FOAK Plant and broader FOAK Program; and the potential relevance of European regulatory, certification, recycled-content, mass-balance and related frameworks to the development and deployment of circular plastics solutions.

Forward-looking information is based on management’s current expectations, estimates, projections, and assumptions, and is subject to known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied. These risks include, but are not limited to, technology development and scale-up risks; delays in advancing the FOAK Program; changes in European regulatory, certification, recycled-content or market frameworks and their implementation; market acceptance of HCT-derived products; the ability to secure and maintain required commercial, feedstock, offtake and project relationships; availability of capital; and other risks described in the Company’s public disclosure filings available on SEDAR+ at www.sedarplus.ca and with the U.S. Securities and Exchange Commission at www.sec.gov.

Readers are cautioned not to place undue reliance on forward-looking information, which speaks only as of the date of this news release. Except as required by applicable law, Aduro undertakes no obligation to update or revise any forward-looking information.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e31d7e4c-f60f-4cb2-9a65-f3aba274a150

TAIPEI, Taiwan and MILPITAS, Calif., Oct. 08, 2026 (GLOBE NEWSWIRE) — Silicon Motion Technology Corporation (NasdaqGS: SIMO) (“Silicon Motion” or the “Company”), a global leader in NAND flash controllers for solid state storage devices, plans to release its third quarter 2026 financial results after the market closes on October 28, 2026 and will host a conference call on October 29 at 8:00 a.m. Eastern Time. Participants must pre-register using the link below to participate in the live call.  

CONFERENCE CALL DETAILS: 
Participants must register in advance to join the conference call using the link provided below. Conference access information (including dial-in information and a unique access PIN) will be provided in the email received upon registration.

Participant Call Registration:
https://register-conf.media-server.com/register/BI5a2f2137ff5446e59f001272500c5465

This call will be webcast on the Company’s website at www.siliconmotion.com.

ABOUT SILICON MOTION:
We are the global leader in supplying NAND flash controllers for solid state storage devices.  We supply more SSD controllers than any other company in the world for servers, PCs and other client devices and are the leading merchant supplier of eMMC and UFS embedded storage controllers used in smartphones, IoT devices and other applications.  We also supply customized high-performance hyperscale data center and specialized industrial and automotive SSD solutions.  Our customers include most of the NAND flash vendors, storage device module makers and leading OEMs.  For further information on Silicon Motion, visit us at www.siliconmotion.com.

FORWARD-LOOKING STATEMENTS:
This news release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” or the negative of these terms or other comparable terminology. Although such statements are based on our own information and information from other sources we believe to be reliable, you should not place undue reliance on them. These statements involve risks and uncertainties, and actual market trends or our actual results of operations, financial condition or business prospects may differ materially from those expressed or implied in these forward-looking statements for a variety of reasons. Potential risks and uncertainties include, but are not limited to, the unpredictable volume and timing of customer orders, which are not fixed by contract but vary on a purchase order basis; the loss of one or more key customers or the significant reduction, postponement, rescheduling or cancellation of orders from one or more customers; general economic conditions or conditions in the semiconductor or consumer electronics markets; the impact of inflation on our business and customers’ businesses and any effect this has on economic activity in the markets in which we operate; the functionalities and performance of our information technology (“IT”) systems, which are subject to cybersecurity threats and which support our critical operational activities, and any breaches of our IT systems or those of our customers, suppliers, partners and providers of third-party licensed technology; the effects on our business and our customers’ business taking into account the ongoing U.S.-China tariffs and trade disputes; other factors beyond our control such as natural disasters, terrorism, civil unrest, war, including conflicts in the Middle East, threats to the Strait of Hormuz and global energy supply routes, and the ongoing Russia-Ukraine War, and pandemics, epidemics and other health emergencies; the continuing tensions between Taiwan and China, including enhanced military activities; decreases in the overall average selling prices of our products; changes in the relative sales mix of our products; supply chain disruptions that have affected us and our industry as well as other industries on a global basis; the payment, or non-payment, of cash dividends in the future at the discretion of our Board of Directors and any announced planned increases in such dividends; changes in our cost of finished goods; the availability, pricing, and timeliness of delivery of other components and raw materials used in the products we sell given the current raw material supply shortages being experienced in our industry; our customers’ sales outlook, purchasing patterns, and inventory adjustments based on consumer demands and general economic conditions; any potential impairment charges that may be incurred related to businesses previously acquired or divested in the future; the risk that the anticipated benefits from our PCIe 5 controller products, including higher average selling prices, may not be maintained or may be less than expected; the risk that our anticipated market share gains across our product lines and penetration of enterprise end markets may not materialize as expected or on the anticipated timeline; our ability to successfully develop, introduce, and sell new or enhanced products in a timely manner; and the timing of new product announcements or introductions by us or by our competitors. For additional discussion of these risks and uncertainties and other factors, please see the documents we file from time to time with the U.S. Securities and Exchange Commission, including our Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission on April 30, 2026. Other than as required under the securities laws, we do not intend, and do not undertake any obligation to, update or revise any forward-looking statements, which apply only as of the date of this news release.         

Investor Contacts:
Tom Sepenzis	Selina Hsieh
Vice President of Investor Relations & Strategy	Investor Relations
tsepenzis@siliconmotion.com	ir@siliconmotion.com

Conference Call to be held Wednesday, October 28, 2026, at 8:00 a.m. Central Time

HOUSTON, Oct. 08, 2026 (GLOBE NEWSWIRE) — Orion Group Holdings, Inc. (NYSE: ORN), a leading specialty construction company, today announced that it will issue its third quarter 2026 financial results after the close of the stock market on Tuesday, October 27, 2026.

A conference call and audio webcast with analysts and investors will be held the next day, Wednesday, October 28, 2026, at 9:00 a.m. Eastern Time/8:00 a.m. Central Time to discuss the results.

• Live conference call: 844-481-2994
• Live and archived webcast: Orion Group Holdings, Inc. – Investor Relations & Shareholder Contact (oriongroupholdingsinc.com)

About Orion Group Holdings, Inc.

Orion Group Holdings, Inc., a leading specialty construction company serving the infrastructure, industrial and building sectors, provides services both on and off the water in the continental United States, Alaska, Hawaii, Canada and the Caribbean Basin through its marine segment and its concrete segment. The Company’s marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. Its concrete segment provides turnkey concrete construction services, including place and finish, site prep, layout, forming, and rebar placement for large commercial, structural and other associated business areas. The Company is headquartered in Houston, Texas with regional offices strategically located across its operating areas. (oriongroupholdingsinc.com)

Contact:

Margaret Boyce
346-278-3762
mboyce@orn.net

Source: Orion Group Holdings, Inc.

LIBERTY CORNER, N.J., Oct. 08, 2026 (GLOBE NEWSWIRE) — Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company, today announced that the United States Patent and Trademark Office (“USPTO”) has granted a new Method of Use patent for certepetide [U.S. Patent No. 12,751,991] for the treatment of pancreatic cancer and other solid tumors, expiring May 2041.

The newly issued patent, titled “Methods for Treating Pancreatic Cancer and Other Solid Tumors,” expands Lisata’s intellectual property protection for certepetide. The patent covers administering the Company’s proprietary cyclic peptide in combination with at least one anti-cancer agent or therapy to treat pancreatic cancer and other solid tumors, including metastatic, refractory, and drug-resistant cancers, by treating, inhibiting, and/or reducing tumor volume.

“This patent granted by USPTO secures important protection for the broad use of certepetide and provides added market exclusivity into November 2043, which is essential to support its continued development,” stated David J. Mazzo, Ph.D., Chief Executive Officer of Lisata.

About Certepetide

Certepetide (formerly LSTA1), an internalizing RGD (arginyl-glycyl-aspartic acid or iRGD), cyclic peptide product candidate, is an investigational drug designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to target and penetrate solid tumors more effectively. Certepetide actuates this active transport system in a tumor-specific manner, resulting in systemically co-administered anti-cancer drugs more efficiently penetrating and accumulating in the tumor. Certepetide also has been shown to modify the tumor microenvironment resulting in tumors which are more susceptible to immunotherapies. We and our collaborators have amassed significant non-clinical data demonstrating enhanced delivery of a range of emerging anti-cancer therapies, including immunotherapies and RNA-based therapeutics. To date, certepetide has also demonstrated favorable safety, tolerability, and clinical activity in completed and ongoing clinical trials designed to test its ability to enhance the effectiveness of standard-of-care chemotherapy for pancreatic cancer

About Lisata Therapeutics

Lisata Therapeutics is a clinical-stage pharmaceutical company. Following its acquisition of Marea Therapeutics, Lisata’s lead product candidate is MAR001, which is in Phase 2b clinical development for the treatment of severe hypertriglyceridemia (sHTG), a condition characterized by very high triglyceride levels. The Company is also advancing MAR002 for the treatment of acromegaly.   Lisata’s cyclic peptide product candidate, certepetide, is an investigational drug designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to selectively target and penetrate solid tumors more effectively. For more information on the Company, please visit www.lisata.com

Forward-Looking Statements

Certain statements in this press release, other than purely historical information, may constitute “forward-looking statements” within the meaning of the federal securities laws, including for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, express or implied statements relating to the company’s expectations, hopes, beliefs, intentions or strategies regarding the future including, without limitation, statements regarding the potential efficacy of certepetide as a treatment for patients with pancreatic cancer and other solid tumors; our beliefs about the potential uses and benefits of certepetide; the expected expiration of our patents for certepetide; our ability to obtain patent term extension on our U.S. composition of matter patent; and our expectations for a long patent runway for certepetide that will support our efforts to maximize its full therapeutic potential; and the potential benefits of MAR001/005 and MAR002. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “opportunity,” “potential,” “milestones,” “pipeline,” “can,” “goal,” “aim,” “strategy,” “target,” “seek,” “anticipate,” “achieve,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “predict,” “project,” “should,” “will,” “would” and similar expressions (including the negatives of these terms or variations of them) may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements are based on current expectations and beliefs concerning future developments and their potential effects. There can be no assurance that future developments affecting the company or the Transaction will be those that have been anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the company’s control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to those uncertainties and factors described under the heading “Risk Factors” in the company’s most recent Annual Report on Form 10-K for the year ended December 31, 2025, filed with the Securities and Exchange Commission (the “SEC”) on March 12, 2026, as well as discussions of potential risks, uncertainties, and other important factors included in other filings by the company from time to time, as well as risk factors associated with companies, such as Marea, that operate in the biotechnology industry. Should one or more of these risks or uncertainties materialize, or should any of the company’s assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Nothing in this press release should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. You should not place undue reliance on forward-looking statements in this press release, which speak only as of the date they are made and are qualified in their entirety by reference to the cautionary statements herein. The company does not undertake or accept any duty to release publicly any updates or revisions to any forward-looking statements. This press release does not purport to summarize all of the conditions, risks and other attributes of an investment in the company.

Contact:

Media and Investors:
Lisata Therapeutics
John Menditto
Investor Relations and Corporate Communications
Email: jmenditto@lisata.com